36. 表皮水疱症 Epidermolysis bullosa Clinical trials / Disease details


臨床試験数 : 163 薬物数 : 185 - (DrugBank : 46) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 125

  
5 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2021-000214-42-ES
(EUCTR)
08/03/202217/12/2021INM-755 cream for patients with EB.A Randomised, Double-Blind, Vehicle-Controlled Phase 2 Study of Topically Applied INM-755 (cannabinol) Cream in Patients with Epidermolysis Bullosa. Epidermolysis bullosa
MedDRA version: 20.0;Level: PT;Classification code 10014989;Term: Epidermolysis bullosa;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
Product Name: Cannabinol (CBN)
Product Code: INM-755
INN or Proposed INN: CANNABINOL
InMed Pharmaceuticals Inc.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
20Phase 2France;Serbia;Greece;Spain;Austria;Israel;Germany;Italy
2EUCTR2021-000214-42-AT
(EUCTR)
01/08/202129/04/2021INM-755 cream for patients with EB.A Randomised, Double-Blind, Vehicle-Controlled Phase 2 Study of Topically Applied INM-755 (cannabinol) Cream in Patients with Epidermolysis Bullosa. Epidermolysis bullosa
MedDRA version: 20.0;Level: PT;Classification code 10014989;Term: Epidermolysis bullosa;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
Product Name: Cannabinol (CBN)
Product Code: INM-755
INN or Proposed INN: CANNABINOL
InMed Pharmaceuticals Inc.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
20Phase 2France;Serbia;Greece;Austria;Israel;Germany;Italy
3EUCTR2021-000214-42-GR
(EUCTR)
22/07/202122/06/2021INM-755 cream for patients with EB.A Randomised, Double-Blind, Vehicle-Controlled Phase 2 Study of Topically Applied INM-755 (cannabinol) Cream in Patients with Epidermolysis Bullosa. Epidermolysis bullosa
MedDRA version: 20.0;Level: PT;Classification code 10014989;Term: Epidermolysis bullosa;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
Product Name: Cannabinol (CBN)
Product Code: INM-755
INN or Proposed INN: CANNABINOL
InMed Pharmaceuticals Inc.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
20Phase 2France;Serbia;Greece;Austria;Israel;Germany;Italy
4EUCTR2021-000214-42-DE
(EUCTR)
19/04/2021INM-755 cream for patients with EB.A Randomised, Double-Blind, Vehicle-Controlled Phase 2 Study of Topically Applied INM-755 (cannabinol) Cream in Patients with Epidermolysis Bullosa. Epidermolysis bullosa
MedDRA version: 20.0;Level: PT;Classification code 10014989;Term: Epidermolysis bullosa;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
Product Name: Cannabinol (CBN)
Product Code: INM-755
INN or Proposed INN: CANNABINOL
InMed Pharmaceuticals Inc.NULLNAFemale: yes
Male: yes
20Phase 2France;Serbia;Greece;Austria;Israel;Germany;Italy
5EUCTR2021-000214-42-FR
(EUCTR)
26/04/2021INM-755 cream for patients with EB.A Randomised, Double-Blind, Vehicle-Controlled Phase 2 Study of Topically Applied INM-755 (cannabinol) Cream in Patients with Epidermolysis Bullosa. Epidermolysis bullosa
MedDRA version: 20.0;Level: PT;Classification code 10014989;Term: Epidermolysis bullosa;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
Product Name: Cannabinol (CBN)
Product Code: INM-755
INN or Proposed INN: CANNABINOL
InMed Pharmaceuticals Inc.NULLNAFemale: yes
Male: yes
20Phase 2Serbia;France;Greece;Austria;Israel;Germany;Italy